Amol Takalkar, MD
Nuclear Medicine · Shreveport, LANPI 1619931060
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,063 of the $8,766 with a category attached, or 69.2%. Progenics Pharmaceuticals, Inc. accounts for 70.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $7,479 and has fallen 87.6% since, to $926 in 2025.
Across 28 payments — averaging $313.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Progenics Pharmaceuticals, Inc.$6K
- Telix Pharmaceuticals$2K
- GE HealthCare$154
- Cardiva Medical, Inc.$103
- Alnylam Pharmaceuticals Inc.$86
- Novartis$56
- plus $168 from 6 others
Across 36 payments — averaging $21,988 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$563K
- Progenics Pharmaceuticals, Inc.$154K
- GE HealthCare$50K
- Novartis$13K
- Bayer$12K
What the payments were for
- Speaking & faculty fees$6,06369%
- Travel & lodging$1,61318%
- Food & beverage$1,07212%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Progenics Pharmaceuticals, Inc. | 6 | $6,175 |
| Telix Pharmaceuticals | 9 | $2,024 |
| GE HealthCare | 2 | $154 |
| Cardiva Medical, Inc. | 1 | $103 |
| Alnylam Pharmaceuticals Inc. | 1 | $86 |
| Novartis | 1 | $56 |
| Eisai Inc. | 1 | $50 |
| Bayer | 2 | $45 |
| Cook Medical LLC | 2 | $25 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Life Molecular Imaging Ltd | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PYLARIFY$6,175
- ILLUCCIX$2,369
- Vascular Closure Device$103
How this compares
Too few nuclear medicine providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Shreveport
- Vani VijayakumarNew Orleans$1K
- Kevin RostetterKenner$137
- Nina GazmenBaton Rouge$119
- Elizabeth GallegosBaton Rouge$30
- Adithya HariBaton Rouge$29
- Lynn WitherspoonNew Orleans$25
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.